These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6381253)

  • 21. Platelet-associated IgG, IgM, and C3 in paediatric infectious disease.
    Forster J; Katzikadamos Z; Zinn P
    Helv Paediatr Acta; 1989 Jun; 43(5-6):415-22. PubMed ID: 2745137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The C3dg Fragment of Complement Is Superior to Conventional C3 as a Diagnostic Biomarker in Systemic Lupus Erythematosus.
    Troldborg A; Jensen L; Deleuran B; Stengaard-Pedersen K; Thiel S; Jensenius JC
    Front Immunol; 2018; 9():581. PubMed ID: 29632534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C3c-binding in inflammatory rheumatic diseases.
    Hautanen A; Gripenberg M; Salonen EM; Julkunen I; Laitinen O
    Clin Exp Rheumatol; 1984; 2(2):125-30. PubMed ID: 6398171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunofluorescent staining of platelet suspensions and detection of antiplatelet antibody in patients with idiopathic thrombocytopenic purpura.
    Boonpucknavig S; Vuttivirojana O; Srichaikul T
    Vox Sang; 1979; 36(2):115-20. PubMed ID: 88810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Platelet immunoglobulins and complement in idiopathic thrombocytopenic purpura. Specificity to the IIb/IIIa membrane complex].
    del Real Llorente M; Alvarez Guisasola FJ
    An Esp Pediatr; 1990 Apr; 32(4):293-8. PubMed ID: 2195940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Idiopathic thrombopenic purpura. Diagnostic and prognostic value of Dixon's test].
    Goudemand J
    Presse Med; 1984 Jun; 13(26):1621-6. PubMed ID: 6234559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunochemical study of incomplete platelet autoantibodies by the anti-globulin consumption test (AGCT) with specific anti-immunoglobulin sera.
    Fagiolo E
    J Immunol Methods; 1976; 9(3-4):225-9. PubMed ID: 942987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular modelling of human complement component C3 and its fragments by solution scattering.
    Perkins SJ; Sim RB
    Eur J Biochem; 1986 May; 157(1):155-68. PubMed ID: 3486762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune thrombocytopenia. Use of a Coombs antiglobulin test to detect IgG and C3 on platelets.
    Cines DB; Schreiber AD
    N Engl J Med; 1979 Jan; 300(3):106-11. PubMed ID: 569254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the mechanism of thrombocytopenic purpura in sexually active homosexual men.
    Walsh CM; Nardi MA; Karpatkin S
    N Engl J Med; 1984 Sep; 311(10):635-9. PubMed ID: 6540841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Quantification of platelet associated IgG in thrombocytopenic purpura (authors transl)].
    Boizard B; Wautier JL; Caen J
    Presse Med (1893); 1979 Dec; 8(48):3943-6. PubMed ID: 575215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of low m.w., C3-bearing immunoglobulin in human serum.
    Jacobs RJ; Reichlin M
    J Immunol; 1983 Jun; 130(6):2775-81. PubMed ID: 6602181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two human monoclonal antiplatelet autoantibodies established from patients with chronic idiopathic thrombocytopenic purpura.
    Honda S; Tsubakio T; Tomiyama Y; Take H; Furubayashi T; Mizutani H; Kurata Y; Yonezawa T; Tarui S
    Br J Haematol; 1990 Jun; 75(2):245-9. PubMed ID: 1695524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of platelet GPIIb/IIIa binding to fibrinogen by serum factors: studies of circulating immune complexes and platelet antibodies in patients with hemophilia, immune thrombocytopenic purpura, human immunodeficiency virus-related immune thrombocytopenic purpura, and systemic lupus erythematosus.
    Kamiyama M; Arkel YS; Chen K; Shido K
    J Lab Clin Med; 1991 Mar; 117(3):209-17. PubMed ID: 2002277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
    Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
    J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the binding of proteins to the human platelet surface: relation to platelet activation.
    Endresen GK; Førre O
    Thromb Haemost; 1985 Jun; 53(3):360-5. PubMed ID: 3901392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody binding to platelet antigens in acute and chronic idiopathic thrombocytopenic purpura: a platelet membrane ELISA for the detection of antiplatelet antibodies in serum.
    Winiarski J; Ekelund E
    Clin Exp Immunol; 1986 Feb; 63(2):459-65. PubMed ID: 3698340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet antibody binding in systemic lupus erythematosus.
    Howe SE; Lynch DM
    J Rheumatol; 1987 Jun; 14(3):482-6. PubMed ID: 3625630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune platelet destruction: idiopathic thrombocytopenic purpura.
    Kelton JG; Gibbons S
    Semin Thromb Hemost; 1982 Apr; 8(2):83-104. PubMed ID: 6210960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.